Caption Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.6K | Sell |
9,700
-159,951
| -94% | -$917K | ﹤0.01% | 469 |
|
|
2025
Q1 | $1.38M | Buy |
169,651
+74,651
| +79% | +$609K | 0.01% | 157 |
|
|
2024
Q4 | $895K | Buy |
+95,000
| New | +$895K | 0.01% | 219 |
|
|
2024
Q3 | – | Sell |
-21,900
| Closed | -$217K | – | 606 |
|
|
2024
Q2 | $217K | Buy |
+21,900
| New | +$217K | ﹤0.01% | 272 |
|
|
2024
Q1 | – | Sell |
-299,500
| Closed | -$4.25M | – | 596 |
|
|
2023
Q4 | $4.25M | Buy |
299,500
+272,500
| +1,009% | +$3.87M | 0.06% | 40 |
|
|
2023
Q3 | $328K | Buy |
27,000
+23,287
| +627% | +$283K | 0.01% | 260 |
|
|
2023
Q2 | $46.6K | Buy |
+3,713
| New | +$46.6K | ﹤0.01% | 304 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 531 |
|
|
2022
Q4 | – | Sell |
-33,400
| Closed | -$349K | – | 586 |
|
|
2022
Q3 | $349K | Buy |
+33,400
| New | +$349K | ﹤0.01% | 268 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 639 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 689 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 707 |
|
|
2021
Q3 | – | Sell |
-47,861
| Closed | -$461K | – | 678 |
|
|
2021
Q2 | $461K | Buy |
+47,861
| New | +$461K | 0.01% | 264 |
|
|
2021
Q1 | – | Sell |
-199,654
| Closed | -$4.61M | – | 524 |
|
|
2020
Q4 | $4.61M | Buy |
199,654
+36,854
| +23% | +$851K | 0.11% | 30 |
|
|
2020
Q3 | $2.3M | Buy |
162,800
+110,974
| +214% | +$1.57M | 0.05% | 62 |
|
|
2020
Q2 | $783K | Buy |
51,826
+34,126
| +193% | +$516K | 0.03% | 129 |
|
|
2020
Q1 | $163K | Buy |
+17,700
| New | +$163K | 0.01% | 232 |
|
|
2019
Q4 | – | Sell |
-15,000
| Closed | -$119K | – | 387 |
|
|
2019
Q3 | $119K | Buy |
+15,000
| New | +$119K | 0.01% | 223 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 319 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 277 |
|
|
2018
Q2 | – | Sell |
-10,000
| Closed | -$151K | – | 209 |
|
|
2018
Q1 | $151K | Buy |
+10,000
| New | +$151K | 0.02% | 84 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 96 |
|